이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Feasibility and Effects of a Realistic Stressful Virtual Environment on Balance and Mobility in Healthy Adults: A Pilot Study

2026년 11월 5일 업데이트: Vrije Universiteit Brussel

Does a Real-life Stressful Virtual Environment Change Balance and Mobility Performance? A Pilot Feasibility Study

The goal of this pilot clinical trial is to evaluate the feasibility of a new approach to assessing balance and mobility in everyday situations by performing established clinical tests in a stressful virtual reality environment. The study involves healthy adults aged 18 years and older with no self-reported neurological disorders or history of epilepsy.

The main questions it aims to answer are:

  1. Is it feasible to perform standard balance and mobility tests in a virtual reality environment simulating a busy train station?
  2. How does this virtual environment affect participants' balance and mobility test performance?
  3. How do participants experience the virtual environment, including their sense of being there and any discomfort or virtual reality sickness?

Researchers will compare each participant's performance with and without virtual reality to see if the virtual environment changes balance and mobility test results.

Participants will:

  • Spend a brief familiarisation period in the virtual environment before testing.
  • Complete the Mini-BESTest, which assesses balance through a series of tasks, with and without virtual reality.
  • Complete the Timed Up and Go test, which involves standing up from a chair, walking three meters, turning, returning, and sitting down, with and without virtual reality and with and without counting backwards by threes.
  • Complete the 10-Meter Walk Test at comfortable and fast walking speeds, with and without virtual reality.
  • Complete questionnaires after the final virtual reality exposure about their sense of being in the virtual environment and any symptoms of discomfort or sickness.

연구 개요

상태

완전한

정황

개입 / 치료

연구 유형

중재적

등록 (실제)

11

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

18년 이상 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

예

연구 대상 성별

모두

설명

Inclusion Criteria:

  • healthy adults aged 18 years and older

Exclusion Criteria:

  • self-reported neurological disorders
  • history of epilepsy

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 다른
  • 할당: 해당 없음
  • 중재 모델: 단일 그룹 할당
  • 마스킹: 없음(오픈 라벨)

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: Balance and mobility assessment with and without virtual reality

All participants complete the Mini-BESTest, Timed Up and Go test, and 10-Meter Walk Test both without a virtual reality headset and while wearing a headset displaying a busy virtual train station. The Timed Up and Go test is performed with and without an additional cognitive task in each condition.

Participants wear a standalone virtual reality headset (Meta Quest 3) displaying a busy train-station environment while completing standard balance and mobility assessments. The environment includes moving pedestrians, animated displays, and recorded train-station sounds. Participants undergo a brief familiarisation period before testing.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Proportion of participants completing all planned assessments
기간: At the end of the single assessment session on Day 1, after completion or discontinuation of the planned assessments.

Proportion of participants who complete all planned assessments in both non-virtual reality (noVR) and virtual reality (VR) conditions. The predefined feasibility criterion is completion by at least 80% of participants.

At the end of the single assessment session on Day 1, after completion or discontinuation of the planned assessments.
Number of virtual reality-related technical issues
기간: From the start of virtual reality system setup to the end of the virtual reality assessments during the single assessment session on Day 1.

technical feasibility: assessed by the number and type of VR-related technical issues encountered

From the start of virtual reality system setup to the end of the virtual reality assessments during the single assessment session on Day 1.
Proportion of complete outcome measurements per test and condition
기간: Data recording during all planned tests in the virtual reality and non-virtual reality conditions within the single assessment session on Day 1.

data completeness: quantified as the proportion of complete outcome data per test and condition (criterion: ≥80% complete data)

Data recording during all planned tests in the virtual reality and non-virtual reality conditions within the single assessment session on Day 1.
Percentage increase in assessment time with virtual reality compared with no virtual reality
기간: From the start to the end of each assessment (mobility and balance assessments) in each condition (virtual reality and non-virtual reality) during the single assessment session on Day 1.

assessment burden: reflected by total assessment time, considered acceptable if VR assessments required no more than 20% additional time compared to noVR conditions

From the start to the end of each assessment (mobility and balance assessments) in each condition (virtual reality and non-virtual reality) during the single assessment session on Day 1.
Number of participants experiencing adverse events during assessment
기간: From the start of the assessment session until 15 minutes after its completion on Day 1, including both virtual reality and non-virtual reality assessments.

Number of participants experiencing at least one adverse event during the assessment session, including both virtual reality and non-virtual reality conditions, or within 15 minutes after its completion.

From the start of the assessment session until 15 minutes after its completion on Day 1, including both virtual reality and non-virtual reality assessments.
Virtual Reality Sickness Questionnaire scores (VRSQ)
기간: single session, Immediately after completion of the virtual reality session on Day 1.

The VRSQ is a modified version of the Simulator Sickness Questionnaire and consists of nine items assessing symptoms of VR-induced discomfort. These items are grouped into two subdomains: oculomotor discomfort (items 1-4) and disorientation (items 5-9). Each item is rated on a four-point Likert scale ranging from 0 ("not at all") to 3 ("severe"). Subscale scores are normalized and combined to yield a total VRSQ score, with higher scores indicating greater VR sickness.

single session, Immediately after completion of the virtual reality session on Day 1.

2차 결과 측정

결과 측정
측정값 설명
기간
iGroup Presence Questionnaire subscale scores
기간: single session, Immediately after completion of the virtual reality session on Day 1.

The IPQ assesses different dimensions of presence and consists of items grouped into four subscales: General Presence (GP), Spatial Presence (SP), Involvement (INV), and Experienced Realism (ER). Items are rated on a seven-point Likert scale ranging from 0 to 6, with higher scores indicating a stronger sense of presence within the virtual environment.

single session, Immediately after completion of the virtual reality session on Day 1.
Within-participant difference in Mini-BESTest total score between virtual reality and non-virtual reality conditions
기간: single session; During Mini-BESTest administration in each condition (virtual reality and non-virtual reality) within the single assessment session on Day 1.

The Mini-Balance Evaluation Systems Test (Mini-BESTest) is a standardized clinical assessment of dynamic balance and a shortened version of the Balance Evaluation Systems Test (BESTest). It consists of 14 items covering four balance domains: anticipatory postural adjustments (items 1-3), reactive postural control (items 4-6), sensory orientation (items 7-9), and dynamic gait (items 10-14) (A.3). Each item is scored on a three-level ordinal scale (0-2), resulting in a maximum total score of 28 points, with higher scores indicating better balance performance. For items requiring bilateral assessment (items 3 and 6), the lower score was retained.

single session; During Mini-BESTest administration in each condition (virtual reality and non-virtual reality) within the single assessment session on Day 1.
Within-participant difference in single-task and cognitive dual-task Timed Up and Go completion time between virtual reality and non-virtual reality conditions
기간: single session; During single-task and cognitive dual-task Timed Up and Go testing in both conditions (virtual reality and non-virtual reality) within the single assessment session on Day 1.

Participants are instructed to stand up from a chair, walk three meters at a safe and comfortable speed, cross a marked line on the floor, turn around, walk back to the chair, and sit down. The time required to complete the task was recorded in seconds. In addition to the standard single-task TUG, a cognitive dual-task version was administered. During the dual-task TUG, participants were asked to count backwards by threes from a randomly selected number between 20 and 100 while performing the motor task. Both single-task and dual-task TUG were performed under noVR and VR conditions, resulting in four TUG conditions in total.

single session; During single-task and cognitive dual-task Timed Up and Go testing in both conditions (virtual reality and non-virtual reality) within the single assessment session on Day 1.
Within-participant difference in comfortable walking speed between virtual reality and non-virtual reality conditions
기간: single session; During comfortable walking speed testing in each condition (virtual reality and non-virtual reality) within the single assessment session on Day 1

The 10-meter walk test was used to assess participants' walking speed. Participants started at the 0-meter (m) mark and walked to the 10 m mark. Timing was performed with a stop watch over the central 6 m, beginning 2 m after the start line and ending 2 m before the end line, to allow for acceleration and deceleration phases and to capture steady-state walking speed. Walking speed (m/s) was calculated by dividing the distance (6 m) by the recorded time (seconds). Two trials were performed at the participant's comfortable walking speed, followed by two trials at their fastest walking speed, according to standardized instructions.

For each speed condition, the two trials were averaged, and the resulting comfortable and fast gait speeds were documented in meters per second.

single session; During comfortable walking speed testing in each condition (virtual reality and non-virtual reality) within the single assessment session on Day 1
Within-participant difference in fast walking speed between virtual reality and non-virtual reality conditions
기간: single session; During fast walking speed testing in each condition (virtual reality and non-virtual reality) within the single assessment session on Day 1.

The 10-meter walk test was used to assess participants' walking speed. Participants started at the 0-meter (m) mark and walked to the 10 m mark. Timing was performed with a stop watch over the central 6 m, beginning 2 m after the start line and ending 2 m before the end line, to allow for acceleration and deceleration phases and to capture steady-state walking speed. Walking speed (m/s) was calculated by dividing the distance (6 m) by the recorded time (seconds). Two trials were performed at the participant's comfortable walking speed, followed by two trials at their fastest walking speed, according to standardized instructions.

For each speed condition, the two trials were averaged, and the resulting comfortable and fast gait speeds were documented in meters per second.

single session; During fast walking speed testing in each condition (virtual reality and non-virtual reality) within the single assessment session on Day 1.

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

스폰서

수사관

  • 수석 연구원: Bart Jansen, PhD, ETRO, Vrije Universiteit Brussel

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2025년 2월 17일

기본 완료 (실제)

2025년 2월 28일

연구 완료 (실제)

2025년 2월 28일

연구 등록 날짜

최초 제출

2026년 10월 19일

QC 기준을 충족하는 최초 제출

2026년 11월 5일

처음 게시됨 (실제)

2026년 11월 12일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 11월 12일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 11월 5일

마지막으로 확인됨

2026년 10월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • ECHW_W_021

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

예

IPD 계획 설명

De-identified individual participant data underlying the results reported in publications arising from this study will be made available by the corresponding author upon reasonable request following publication.

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .